What You Should Know:
– DeepScribe, the ambient AI of choice for specialty care, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, today announced a…
Continue Reading
GE HealthCare Technologies Inc. and the University of California San Francisco and its Department of Radiology and Biomedical Imaging have formed a new partnership to collaborate on advanced imaging and precision oncology, the company…
Continue Reading
Digital twins in precision medicine provide tailored health recommendations by simulating patient-specific trajectories and interventions. We examine the critical role of Verification, Validation, and Uncertainty Quantification (VVUQ) for digital twins in ensuring safety and…
Continue Reading
What You Should Know:
– Guardant Health, a provider in precision oncology, and ConcertAI, a real-world evidence (RWE) and AI technology company in oncology, announced a strategic collaboration that will provide biopharmaceutical companies with access…
Continue Reading
What You Should Know:
– Caris Life Sciences® (Caris), a pioneer in precision medicine and next-generation AI TechBio innovation, announced a transformative collaboration with Ontada®, a leading organization in oncology real-world evidence, clinical education, and point-of-care technologies.
– …
Continue Reading
Noam Solomon, CEO at Immunai
For over a decade, we’ve heard about AI’s transformative potential in therapeutics (Tx), but where’s the evidence? Has it all been hype? Can AI still revolutionize Tx? Or is there…
Continue Reading
Drug discovery startup Insilico Medicine and Italian pharmaceutical company Menarini Group announced their second licensing agreement, targeting unmet needs in oncology with a novel AI-discovered preclinical asset. The agreement grants Stemline Therapeutics, a subsidiary of…
Continue Reading
What You Should Know:
– ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
– ScreenPoint’s…
Continue Reading
What You Should Know:
– Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced its upcoming acquisition by Renovaro, Inc. (NASDAQ: RENB) in a strategic move aimed at accelerating innovation and improving…
Continue Reading
As 2024 comes to a close, MobiHealthNews asked executives from across the digital health sector about their biggest surprises and most noteworthy events from the year. The execs highlight AI’s potential, oncology imaging breakthroughs, nutrition’s…
Continue Reading
